These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

339 related articles for article (PubMed ID: 22340451)

  • 21. Comparing clinical features of the nebulizer, metered-dose inhaler, and dry powder inhaler.
    Geller DE
    Respir Care; 2005 Oct; 50(10):1313-21; discussion 1321-2. PubMed ID: 16185367
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Inhaled drug delivery in the hands of the patient.
    Lavorini F
    J Aerosol Med Pulm Drug Deliv; 2014 Dec; 27(6):414-8. PubMed ID: 25238005
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Numerical simulation of the effect of inhalation parameters, gender, age and disease severity on the lung deposition of dry powder aerosol drugs emitted by Turbuhaler®, Breezhaler® and Genuair® in COPD patients.
    Horváth A; Farkas Á; Szipőcs A; Tomisa G; Szalai Z; Gálffy G
    Eur J Pharm Sci; 2020 Nov; 154():105508. PubMed ID: 32836137
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The development of a novel dry powder inhaler.
    Zhang X; Ma Y; Zhang L; Zhu J; Jin F
    Int J Pharm; 2012 Jul; 431(1-2):45-52. PubMed ID: 22543053
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Safety and pharmacokinetics of multiple doses of aclidinium bromide, a novel long-acting muscarinic antagonist for the treatment of chronic obstructive pulmonary disease, in healthy participants.
    Jansat JM; Lamarca R; de Miquel G; Schrödter A; Miletzki B; Gurniak M
    J Clin Pharmacol; 2009 Oct; 49(10):1239-46. PubMed ID: 19592595
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Tiotropium administered by a pressurized metered dose inhaler (pMDI) and spacer produces a similar bronchodilator response as that administered by a Rotahaler in adult subjects with stable moderate-to-severe COPD.
    Brashier B; Dhembare P; Jantikar A; Mahadik P; Gokhale P; Gogtay JA; Salvi SS
    Respir Med; 2007 Dec; 101(12):2464-71. PubMed ID: 17719763
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Identifying the features of an easy-to-use and intuitive dry powder inhaler for asthma and chronic obstructive pulmonary disease therapy: results from a 28-day device handling study, and an airflow resistance study.
    Virchow JC; Weuthen T; Harmer QJ; Jones S
    Expert Opin Drug Deliv; 2014 Dec; 11(12):1849-57. PubMed ID: 25151851
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Sustained mechanical and clinical functionality of the flexhaler dry powder inhaler.
    Lööf T; Elfman P; Ström P; Törngren A; Borgström L
    J Aerosol Med Pulm Drug Deliv; 2008 Dec; 21(4):381-8. PubMed ID: 18823260
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Practical problems with aerosol therapy in COPD.
    Rau JL
    Respir Care; 2006 Feb; 51(2):158-72. PubMed ID: 16441960
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Dose emission characteristics of placebo PulmoSphere® particles are unaffected by a subject's inhalation maneuver.
    Weers J; Ung K; Le J; Rao N; Ament B; Axford G; Maltz D; Chan L
    J Aerosol Med Pulm Drug Deliv; 2013 Feb; 26(1):56-68. PubMed ID: 22691109
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Pharmacokinetics and safety of aclidinium bromide in younger and elderly patients with chronic obstructive pulmonary disease.
    de la Motte S; Beier J; Schmid K; Pascual S; Jansat JM; Gil EG
    Int J Clin Pharmacol Ther; 2012 Jun; 50(6):403-12. PubMed ID: 22541745
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Key issues in inhalation therapy in children.
    Brand PL
    Curr Med Res Opin; 2005; 21 Suppl 4():S27-32. PubMed ID: 16138942
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Characteristics of a capsule based dry powder inhaler for the delivery of indacaterol.
    Pavkov R; Mueller S; Fiebich K; Singh D; Stowasser F; Pignatelli G; Walter B; Ziegler D; Dalvi M; Dederichs J; Rietveld I
    Curr Med Res Opin; 2010 Nov; 26(11):2527-33. PubMed ID: 20843166
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Can patients use all dry powder inhalers equally well?
    Gustafsson P; Taylor A; Zanen P; Chrystyn H
    Int J Clin Pract Suppl; 2005 Dec; (149):13-8. PubMed ID: 16279998
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Inhaler devices - from theory to practice.
    Sanchis J; Corrigan C; Levy ML; Viejo JL;
    Respir Med; 2013 Apr; 107(4):495-502. PubMed ID: 23290591
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Genuair is a good inhaler but an indirect comparison with other dry powder inhalers is inadequate.
    Cazzola M
    Respiration; 2009; 78(3):249-51; discussion 252. PubMed ID: 19546520
    [No Abstract]   [Full Text] [Related]  

  • 37. [Powder inhalation systems].
    Kohlhäufl M; Haidl P; Voshaar T; Häussinger K; Köhler D
    Dtsch Med Wochenschr; 2004 Sep; 129(39):2048-52. PubMed ID: 15386209
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Satisfaction, preference and error occurrence of three dry powder inhalers as assessed by a cohort naïve to inhaler operation.
    Man KN; Tian Z; Lam DC; Wan JMF; Tan-Un KC
    Int J Chron Obstruct Pulmon Dis; 2018; 13():1949-1963. PubMed ID: 29942127
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Inspiratory flow profile and usability of the NEXThaler, a multidose dry powder inhaler, in asthma and COPD.
    Chetta A; Yorgancioglu A; Scuri M; Barile S; Guastalla D; Dekhuijzen PNR
    BMC Pulm Med; 2021 Feb; 21(1):65. PubMed ID: 33632183
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Demystifying Dry Powder Inhaler Resistance with Relevance to Optimal Patient Care.
    Capstick TGD; Gudimetla S; Harris DS; Malone R; Usmani OS
    Clin Drug Investig; 2024 Feb; 44(2):109-114. PubMed ID: 38198116
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 17.